Carmustine

Spezifikationen

154-93-8CAS-Nummer

205-838-2EG-Nummer

1,3-bis(2-chloroethyl)-1-nitrosoureaIUPAC-Name

C5H9Cl2N3O2Chemische Formel

214.05 g/molMolekulargewicht

carmustine; 154-93-8; 1,3-Bis(2-chloroethyl)-1-nitrosourea; BCNU; Carmustin; Nitrumon; Carmubris; BiCNU; Becenun; Bischloroethyl nitrosourea; Carmustina; Carmustinum; Bischlorethylnitrosurea; N,N'-BIS(2-CHLOROETHYL)-N-NITROSOUREA; Bischlorethylnitrosourea; Becenum; NSC-409962; Urea, N,N'-bis(2-chloroethyl)-N-nitroso-; Bischloroethylnitrosourea; FDA 0345; SRI 1720; SK 27702; NCI-C04773; DTXSID8022743; Camustine; Carustine; NSC 409962; 1,3-Bis(beta-chloroethyl)-1-nitrosourea; NSC409962; 1,3-bis(2-chloroethyl)-3-nitrosourea; SK-27702; DTI-015; Urea, 1,3-bis(2-chloroethyl)-1-nitroso-; U68WG3173Y; bis-chloroethylnitrosourea; FDA-0345; SRI-1720; CHEBI:3423; DTXCID002743; FIVB; Nitrourean; RefChem:57681; bis(chloroethyl) nitrosourea; L01AD01; WR-139021; 205-838-2; Bis-Chloronitrosourea; Gliadel; 1,3-Bis(2-chloroethyl)nitrosourea; Bi CNU; Bis(2-chloroethyl)nitrosourea; BiCNU (TN); DTI 015; Carmustine (98%); Bis(chloroethyl)nitrosourea; MFCD00057706; CHEMBL513; 1,3-bis(2-chloroethyl)-1-nitroso-urea; NCGC00015204-05; 1,3-Bis(.beta.-chloroethyl)-1-nitrosourea; Gliadel Wafer; Carmustinum [INN-Latin]; Carmustina [INN-Spanish]; Bis(2-chloroethyl)1-nitrosourea; Bis-N,N'-(chloroethyl)nitrosourea; CAS-154-93-8; CCRIS 810; BCNU [Chloroethyl nitrosoureas]; Carmustine; 1,3-bis(2-chloroethyl)-1-nitrosourea; SR-01000075736; EINECS 205-838-2; BRN 2049744; UNII-U68WG3173Y; Carmustine?; AI3-52216; Carmubris;; Becenum;; Carmustine CRS; HSDB 7761; Carmustine [USAN:USP:INN:BAN]; Prestwick_997; Gliadel (TN); Bischloroethyl nitrosourea [Chloroethyl nitrosoureas]; Carmustine (Standard); Gliadel (MGI Pharm); Spectrum_000265; Carmustine, >=98%; CARMUSTINE [MI]; CARMUSTINE [INN]; CARMUSTINE [JAN]; Spectrum4_000888; Spectrum5_000920; CAMUSTINE [VANDF]; CARMUSTINE [HSDB]; CARMUSTINE [USAN]; Lopac-C-0400; WLN: ONN2GVM2G; C 0400; CARMUSTINE [MART.]; SCHEMBL4503; CARMUSTINE [USP-RS]; CARMUSTINE [WHO-DD]; Lopac0_000188; Carmustine (JAN/USP/INN); KBioGR_001296; KBioSS_000745; MLS001333962; DivK1c_000835; Carmustine - Bio-X trade mark; GTPL6800; orb1304551; CARMUSTINE [EP IMPURITY]; CARMUSTINE [ORANGE BOOK]; HMS502J17; KBio1_000835; KBio2_000745; KBio2_003313; KBio2_005881; CARMUSTINE [EP MONOGRAPH]; NINDS_000835; CARMUSTINE [USP MONOGRAPH]; GLXC-05943; HMS2092J22; HMS2230I05; HMS3260F17; HMS3369D17; HMS5081L16; Pharmakon1600-01503110; Tox21_110097; Tox21_500188; BDBM50015950; CCG-39925; EBC-08119; HY-13585R; MSK164269; NSC758392; STK624770; AKOS005558013; Tox21_110097_1; DB00262; FC19817; LP00188; NSC-758392; SDCCGSBI-0050176.P004; IDI1_000835; Urea,3-bis(2-chloroethyl)-1-nitroso-; BISCHLOROETHYL NITROSOUREA [IARC]; NCGC00015204-01; NCGC00015204-02; NCGC00015204-03; NCGC00015204-04; NCGC00015204-06; NCGC00015204-07; NCGC00015204-08; NCGC00015204-09; NCGC00015204-15; NCGC00015204-18; NCGC00093665-01; NCGC00093665-02; NCGC00093665-03; NCGC00093665-04; NCGC00260873-01; Urea,N'-bis(2-chloroethyl)-N-nitroso-; AC-24196; AS-12106; BC164289; HY-13585; N,N''-Bis(2-chloroethyl)-N-nitrosourea; NCI60_003931; SMR000058426; SBI-0050176.P003; C2634; EU-0100188; NS00005564; S3669; T3091; A12097; BCNU; 1,3-Bis(2-chloroethyl)-1-nitrosourea; C06873; D00254; EN300-123541; AB00052431-07; AB00052431_08; F828460; Q415869; SR-01000075736-1; SR-01000075736-3; (Z)-N,N'-bis(2-chloroethyl)-N-nitrosocarbamimidic acid; Z1269141329; Carmustine, United States Pharmacopeia (USP) Reference Standard; N,N'-Bis(2-chloroethyl)-N-nitrosourea, NSC-409962, Becenun; 1-(2-Chloroethyl)-1-([(2-chloroethyl)amino]carbonyl)-2-oxohydrazine #Synonyme